These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6418064)

  • 1. Susceptible Escherichia coli cells can actively excrete tetracyclines.
    McMurry LM; Aronson DA; Levy SB
    Antimicrob Agents Chemother; 1983 Oct; 24(4):544-51. PubMed ID: 6418064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains.
    McMurry LM; Cullinane JC; Levy SB
    Antimicrob Agents Chemother; 1982 Nov; 22(5):791-9. PubMed ID: 6758689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.
    Nelson ML; Park BH; Andrews JS; Georgian VA; Thomas RC; Levy SB
    J Med Chem; 1993 Feb; 36(3):370-7. PubMed ID: 8426364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of tetracyclines through the bacterial cell membrane assayed by fluorescence: a study with susceptible and resistant strains of Staphylococcus aureus and Escherichia coli.
    Samra Z; Krausz-Steinmetz J; Sompolinsky D
    Microbios; 1978; 21(83):7-21. PubMed ID: 375035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of tetracyclines by Escherichia coli K-12.
    Ball PR; Chopra I; Eccles SJ
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1500-7. PubMed ID: 332179
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of tetracycline and minocyclie transport in Escherichia Coli.
    Del Bene VE; Rogers M
    Antimicrob Agents Chemother; 1975 Jun; 7(6):801-6. PubMed ID: 1098571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for broken minocycline by NMR and HPLC techniques: a new additional resistance mechanism mediated by tetB determinant.
    Jupeau-Vessières AN; Leroux YG; Scavizzi MR; el Manouni D; Gerbaud GR
    Res Microbiol; 1989; 140(3):207-19. PubMed ID: 2694246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of tetracyclines into Escherichia coli requires a carboxamide group at the C2 position of the molecule.
    Chopra I
    J Antimicrob Chemother; 1986 Dec; 18(6):661-6. PubMed ID: 3546242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
    Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of protein synthesis in Escherichia coli to tetracycline and minocycline.
    Chopra I; Shales S
    J Gen Microbiol; 1981 May; 124(1):187-9. PubMed ID: 7033463
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).
    Hirata T; Saito A; Nishino K; Tamura N; Yamaguchi A
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2179-84. PubMed ID: 15155219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines.
    Hope R; Warner M; Mushtaq S; Ward ME; Parsons T; Livermore DM
    J Antimicrob Chemother; 2005 Dec; 56(6):1042-6. PubMed ID: 16286361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines.
    Tuckman M; Petersen PJ; Projan SJ
    Microb Drug Resist; 2000; 6(4):277-82. PubMed ID: 11272255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the mechanism of action of minocycline and of certain other tetracycline group compounds].
    Beliavskaia IV; Kukhanova MK; Sazykin IUu ; Navashin SM
    Antibiotiki; 1976 Mar; 21(3):242-5. PubMed ID: 776077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli.
    Shales SW; Chopra I; Ball PR
    J Gen Microbiol; 1980 Nov; 121(1):221-9. PubMed ID: 7019387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Acinetobacter calcoaceticus var. anitratus (Herellea vaginicola) to minocycline.
    Montgomerie JZ; Pickett MJ; Yoshimori RN; Chow AW; Guze LB
    Antimicrob Agents Chemother; 1976 Jul; 10(1):102-5. PubMed ID: 791084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tetracyclines: bacteriostatic or bactericidal drugs? In vitro studies with rolitetracycline, minocycline and doxycycline (author's transl)].
    Daschner F
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):527-34. PubMed ID: 345688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of minocycline and tetracycline by tetracycline-susceptible and -resistant bacteria.
    Kuck NA; Forbes M
    Antimicrob Agents Chemother; 1973 Jun; 3(6):662-4. PubMed ID: 4597735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active accumulation of tetracycline by Escherichia coli.
    Franklin TJ; Higginson B
    Biochem J; 1970 Jan; 116(2):287-97. PubMed ID: 4984165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.